Personalized Bioactive Extract Generation Platform

Publication ID: 24-11857587_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Bioactive Extract Generation Platform,” Published Technical Disclosure No. 24-11857587_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857587_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,587.

Summary of the Inventive Concept

A system for creating customized bioactive extracts using machine learning, genomic data, and vertically-integrated fermentation, enabling personalized health and wellness solutions.

Background and Problem Solved

The original patent relates to a composition including fungal extract components from medicinal fungal species, but it lacks personalization and scalability. The new inventive concept addresses these limitations by integrating machine learning, genomic data, and advanced fermentation techniques to generate customized bioactive extracts tailored to individual user health profiles.

Detailed Description of the Inventive Concept

The new inventive concept consists of a database of genomic information from various medicinal fungal species, a machine learning algorithm for predicting optimal fungal species combinations based on individual user health profiles, and a fermentation chamber for producing customized extracts. The system can create a virtual bioactive extract library, predict potential bioactive compounds and their interactions, and generate a digital repository of virtual extracts for further analysis and development. The platform can also integrate with wearable devices, decentralized fermentation facilities, and CRISPR-Cas9 gene editing for targeted bioactive compound production, enabling a personalized health and wellness system.

Novelty and Inventive Step

The new claims introduce a paradigm shift in bioactive extract generation by leveraging machine learning, genomic data, and advanced fermentation techniques to create personalized, scalable, and adaptive solutions. The inventive step lies in the integration of these components to generate customized bioactive extracts, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments could include using different machine learning algorithms, incorporating additional data sources such as environmental or lifestyle factors, or developing modular fermentation systems for decentralized production. Variations could also involve integrating the platform with existing healthcare systems, developing new interfaces for user input, or creating a marketplace for bioactive extract trading.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the health and wellness industry, particularly in the areas of personalized medicine, nutrition, and disease prevention. The market for customized bioactive extracts is expected to grow rapidly, driven by increasing demand for tailored health solutions and advancements in genomics, machine learning, and fermentation technologies.

CPC Classifications

SectionClassGroup
A A61 A61K36/074
A A61 A61K36/185
A A61 A61K2236/333

Field of Art

Biotechnology and pharmaceutical sciences, specifically focused on medicinal fungal extract production, genomic analysis, and personalized health technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biotechnology, microbiology, or pharmaceutical sciences, possessing expertise in genomic sequencing, machine learning applications in biological systems, fermentation techniques, and computational biology

Obviousness Rationale

A PHOSITA would recognize that the PTD represents a predictable technological progression from the source patent by applying standard computational and biotechnological techniques to enhance fungal extract production. The integration of machine learning, genomic analysis, and personalized extract generation follows established technological trends in precision medicine and biotechnology. The disclosed variations represent logical extensions of existing knowledge in fungal extract research and personalized health technologies.

Obvious Combinations & Variations

Source Patent Element
Fungal extract production method using specific medicinal fungal species like Ganoderma lucidium
PTD Variation
Machine learning-driven platform for predicting optimal fungal species combinations based on genomic data
Obviousness Reasoning
Applying computational methods to optimize biological extract production is a known technique in biotechnology, representing a predictable application of machine learning to existing extraction processes
Source Patent Element
Extraction of bioactive compounds from fungal mycelia
PTD Variation
Creating a virtual bioactive extract library using computational modeling and genomic sequencing
Obviousness Reasoning
Computational modeling of biological compounds is a standard approach in pharmaceutical research, representing an obvious technological progression for extract characterization
Source Patent Element
Composition with antiviral, antibacterial, and immune-boosting activities
PTD Variation
Personalized health platform integrating wearable device data with bioactive extract recommendations
Obviousness Reasoning
Combining health monitoring technologies with targeted biological interventions is a predictable evolution in precision medicine and personalized health technologies
Source Patent Element
Fungal extract production using specific growth substrates like rice and wheat
PTD Variation
Modular, vertically-integrated fermentation system with AI-powered quality control
Obviousness Reasoning
Implementing advanced monitoring and optimization techniques in biological production represents an obvious technological improvement using standard engineering principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857587 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed personalized bioactive extract generation platform obvious and anticipated, as the disclosed methods represent predictable technological extensions employing standard computational, genomic, and biotechnological techniques to enhance fungal extract production and personalized health interventions.

Original Patent Information

Patent NumberUS 11,857,587
TitleBioactive extract